Use of interferon-gamma release assay (IGRA) and CXCL-10/IP-10 for latent tuberculosis infection (LTBI) screening in chronic kidney disease and hemodialysis patients.

IF 3 3区医学 Q2 INFECTIOUS DISEASES

BMC Infectious Diseases Pub Date : 2025-10-02 DOI:10.1186/s12879-025-11620-z

Juliana Cristina Borges da Silva, Nathália Barcellos Vieira, Marcelo Ribeiro-Alves, Roberto Stefan de Almeida Ribeiro, Carla Cavalheiro da Silva Lemos, Renata Mendes, Conrado Lysandro Rodrigues Gomes, Ana Paula Santos, José Hermógenes Suassuna, Rachel Bregman, Luciana Silva Rodrigues

引用次数: 0

查看原文本刊更多论文

干扰素γ释放试验（IGRA）和CXCL-10/IP-10在慢性肾病和血液透析患者潜伏性结核感染（LTBI）筛查中的应用

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Infectious Diseases 医学-传染病学

CiteScore

6.50

自引率

0.00%

发文量

860

审稿时长

3.3 months

期刊介绍： BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.